Skip to main content
. Author manuscript; available in PMC: 2007 Dec 10.
Published in final edited form as: J Subst Abuse Treat. 2007 Jan 9;32(4):399–409. doi: 10.1016/j.jsat.2006.10.005

Table 4.

Differential diagnosis of aberrant drug-taking behaviors in the HIV-infected patient

Addiction
Pseudoaddiction
Metabolic conditions (e.g., producing encephalopathy)
Infectious process (e.g., neurocognitive effects of HIV, HCV, or both)
Mental Health Axis I (e.g., depression, bipolar disorder)
Mental Health Axis II (e.g., borderline personality disorder)
Social stressorsa
a

Such as family dysfunctions or the desire to divert medications for money.